Illinois General Assembly - Full Text of HB2600

LRB104 10346 JRC 20420 b

104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
HB2600

Introduced 2/6/2025, by Rep. Adam M. Niemerg

SYNOPSIS AS INTRODUCED:

New Act

Creates the COVID-19 Vaccination Employer Mandate Prohibition Act. Provides that it is unlawful for an employer in the State of Illinois to create, implement, or otherwise enforce a workplace vaccination program that requires any employee to demonstrate to the employer that he or she has received a vaccine or its related booster that was approved under emergency use authorization by the United States Food and Drug Administration. Effective immediately.

A BILL FOR

AN ACT concerning employment.

Be it enacted by the People of the State of Illinois, represented in the General Assembly:

Section 1. Short title. This Act may be cited as the COVID-19 Vaccination Employer Mandate Prohibition Act.

Section 5. Purpose. It is the purpose of this Act to allow individuals to have the bodily autonomy to make the decision of whether or not to receive a vaccination or its related booster that was approved by the United States Food and Drug Administration to be used under emergency use authorization for treatment of COVID-19. The fact that the vaccines made available amid the global pandemic have been granted emergency use authorization means that both regulatory bodies and industry experts have not been allotted sufficient time to study either the short-term and long-term effects that may arise from the administration of vaccinations authorized for emergency use. Additionally, since COVID-19 is no longer categorized as a pandemic, the need for vaccine mandates is no longer present. Therefore, the State is compelled to prohibit employers from requiring that employees receive a vaccine or its related booster that has been approved under emergency use authorization as a condition of employment.

Section 10. Prohibition. It is unlawful for an employer in this State to create, implement, or otherwise enforce a workplace vaccination program that requires an employee to demonstrate to the employer that he or she has received a vaccine or its related booster that was approved under emergency use authorization by the United States Food and Drug Administration, under the Administration's power outlined in Section 564 of the Federal Food, Drug, and Cosmetic Act, for protection against COVID-19.

Section 99. Effective date. This Act takes effect upon becoming law.